Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/1999
02/23/1999US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
02/23/1999US5874533 HIV-2 envelope polypeptides
02/23/1999US5874531 Polypeptides implicated as self epitope in autoimmune disease pemphigus vulgaris and multiple scelerosis
02/23/1999US5874528 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbB-2 receptor
02/23/1999US5874527 Plasmodium vivax blood stage antigens
02/23/1999US5874526 Toxoplasma gondii antigens
02/23/1999US5874409 Antiphospholipid analog specifically binds antibodies produced by b cells specific for an antiphospholipid epitope and lacks t cell epitopes; where in the analog is a oligopeptide or polypeptide
02/23/1999US5874401 Cedar pollen protein and use thereof in treating, preventing, and diagnosing pollenosis
02/23/1999US5874316 Receptor membranes and ionophore gating
02/23/1999US5874314 Heating a conductive device in a pulsed fashion to thermally ionize molecules; an electrode collects emitted ions, and the resulting current is amplified; heat pulse lasts until no current is detected; low voltage fire detectors
02/23/1999US5874313 Method for quantifying oxidation parameters of low density lipoproteins and use thereof
02/23/1999US5874312 Diagnosis of alzheimer disease stage by mononuclear cell cytokine secretions
02/23/1999US5874311 Simple and efficient quantitative analysis of blood sample by cytolysis of mature erthyrocytes, measuring low angle light scatter signal without staining or fluorescence
02/23/1999US5874310 Method for differentiation of nucleated red blood cells
02/23/1999US5874309 Exposing patterned metals to a corrosion-accelerating environment, calculating the difference in defects between before and after the treatment; stopping and correcting process used to make wafer if corrosion is excessive
02/23/1999US5874305 Androgen-repressed metastatic human prostate cancer cell line
02/23/1999US5874304 Humanized green fluorescent protein genes and methods
02/23/1999US5874303 Sustainable cell line for the production of Marek's disease vaccines
02/23/1999US5874300 Campylobacter jejuni antigens and methods for their production and use
02/23/1999US5874266 Targeted system for removing tumor cells from cell populations
02/23/1999US5874264 Retrovirus
02/23/1999US5874256 Obtaining a sample that contains blood coagulation factor v or factor and assaying for presence of a mutation in amino acid 506 (arginine to glutamine) of human factor v or va caused by decreased deactivation by activated protein c
02/23/1999US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor
02/23/1999US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3
02/23/1999US5874245 Human G-protein coupled receptor (HIBCD07)
02/23/1999US5874237 Method and apparatus for collecting airborne biological particles
02/23/1999US5874236 DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
02/23/1999US5874235 Nonsteroidal antiinflammatory agents for increase of ceramids mediated with cyclooxygenase inhibition
02/23/1999US5874233 Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
02/23/1999US5874232 Relating to assay reagents
02/23/1999US5874231 Contacting test agent with complex comprising translation factor sequestered by cell component wherein said complex responds to hormone treatment by releasing translation factor from sequestration; detecting if test agent causes release
02/23/1999US5874227 Binds to corticotropin factor; competitive binding assay for screening ligands
02/23/1999US5874226 In situ immunodetection of antigens
02/23/1999US5874225 Cell line from human rhabdomyosarcoma cell line te671. differentiated cells are characterized by great enlargement
02/23/1999US5874222 M6P/IGF-II receptor tumor suppressor gene
02/23/1999US5874218 Method for detecting a target compound in a substance using a nucleic acid ligand
02/23/1999US5874216 Chromatographic strip positive readout competitive binding assay device
02/23/1999US5874211 Chemokine expressed in eosinophils
02/23/1999US5874209 Regulation of transcription factor, NF-IL6/LAP
02/23/1999US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide
02/23/1999US5874047 Etching a body of silicon from an active surface to form a pore network penetrating into body forming a foam structure, lining the pores with nonconductor boundary layer, depositing in the pores reactive materials such as antibody, enzymes
02/23/1999US5873997 Bioreactor and method of measuring contaminants in an aqueous environment
02/23/1999US5873990 Handheld electromonitor device
02/23/1999US5873980 Apparatus and method for recovering solvent
02/23/1999US5873328 Pet leash with length-limited elastic section
02/23/1999CA2176673C Improved sealant for sample holder
02/23/1999CA2136088C Apparatus for drawing fluid sample, components thereof, and a slide assembly for use therewith
02/23/1999CA2050941C Antibody to smooth muscle myosin heavy chains
02/23/1999CA1340405C Method for detecting antibodies to human immunodeficiency virus
02/23/1999CA1340403C Human b lymphotropic virus (hblv) isolation and products
02/22/1999CA2245464A1 Method for examining the foaming behavior of liquids
02/21/1999CA2241428A1 Asp5
02/20/1999CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor
02/19/1999CA2245310A1 Sca7 gene and methods of use
02/19/1999CA2241433A1 Novel compounds
02/18/1999WO1999008246A1 Carbon monoxide and smoke detection apparatus
02/18/1999WO1999008233A1 A digital imaging system for assays in well plates, gels and blots
02/18/1999WO1999008114A1 Hydrophobic fluorescent polymer membrane for the detection of ammonia
02/18/1999WO1999008113A1 Antigens embedded in thermoplastic
02/18/1999WO1999008112A1 Methods of identifying biological agent compositions
02/18/1999WO1999008111A1 Method for monitoring airborne chemicals
02/18/1999WO1999008110A1 Methods and compositions for overcoming resistance to biologic and chemotherapy
02/18/1999WO1999008109A2 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
02/18/1999WO1999008108A1 Determining the transforming capability of agents
02/18/1999WO1999008107A1 Aggregometer with disposable test cell
02/18/1999WO1999008106A1 A method of determining the concentration of an analyte with the use of a bioelement and a device operating in accordance with the method
02/18/1999WO1999008105A1 Techniques and systems for analyte detection
02/18/1999WO1999008104A1 On-line analysis of process gas during the production of ketene
02/18/1999WO1999008102A1 Gas detection device and method
02/18/1999WO1999008095A1 Analytical cartridge
02/18/1999WO1999008091A1 System and method for automatically detecting malignant cells and cells having malignancy-associated changes
02/18/1999WO1999008086A1 Gas analysing apparatus
02/18/1999WO1999007897A1 Magnetic polynucleotide separation and analysis
02/18/1999WO1999007894A1 Direct quantitation of low copy number rna
02/18/1999WO1999007892A1 Array-based detection of genetic alterations associated with disease
02/18/1999WO1999007891A1 90 human secreted proteins
02/18/1999WO1999007882A1 Fluorescent polymeric sensor for the detection of urea
02/18/1999WO1999007881A1 Fluorescent polymeric sensor for the detection of creatinine
02/18/1999WO1999007880A1 IDENTIFICATION OF HUMAN ALLERGENS AND T-LYMPHOCYTE ANTIGENS $i(IN VITRO)
02/18/1999WO1999007879A1 Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
02/18/1999WO1999007876A2 Method for assaying cellular protein
02/18/1999WO1999007856A1 Novel metalloprotease
02/18/1999WO1999007855A1 Neutral sphingomyelinase
02/18/1999WO1999007850A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
02/18/1999WO1999007848A1 Mammalian cytokine receptor-11
02/18/1999WO1999007843A1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith
02/18/1999WO1999007837A1 Isolation and identification of novel polymerases
02/18/1999WO1999007832A1 Kcnq potassium channels and methods of modulating same
02/18/1999WO1999007823A1 Method and apparatus for separating particulate matter from a liquid specimen
02/18/1999WO1999007750A1 Perfluorinated resins as a support for solid phase reactions
02/18/1999WO1999007737A2 Lsr receptor, cloning and uses
02/18/1999WO1999007736A2 Lipoprotein-regulating medicaments
02/18/1999WO1999007728A2 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances
02/18/1999WO1999007726A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
02/18/1999WO1999007471A1 System for providing biological materials
02/18/1999WO1999007353A1 USE OF α1A-ADRENERGIC RECEPTOR ANTAGONISTS IN GLAUCOMA THERAPY
02/18/1999WO1999007325A1 Liver function test
02/18/1999WO1998053311A3 Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system
02/18/1999WO1998049290A3 Syndecan interacting proteins and the use thereof
02/18/1999WO1998042833A3 Kv potassium channel polypeptides and polynucleotides